These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 35180547)

  • 1. Silencing of circ_OSBPL10 affects the functional behaviors of oral squamous cell carcinoma cells by the miR-299-3p/CDK6 axis.
    Tai Y; Li Y; Zhang M
    Arch Oral Biol; 2022 Apr; 136():105363. PubMed ID: 35180547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role and mechanism of circ-BNC2 on the malignant progression of oral squamous cell carcinoma.
    Xia Y; Hei N; Peng S; Cui Z
    Head Neck; 2023 Sep; 45(9):2424-2437. PubMed ID: 37377048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ_0005320 promotes oral squamous cell carcinoma tumorigenesis by sponging microRNA-486-3p and microRNA-637.
    Zheng X; Du F; Gong X; Xu P
    Bioengineered; 2022 Jan; 13(1):440-454. PubMed ID: 34967281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
    Zhou Y; Zhang S; Min Z; Yu Z; Zhang H; Jiao J
    BMC Cancer; 2021 Oct; 21(1):1085. PubMed ID: 34620126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propofol inhibits the proliferation, invasion, migration, and angiogenesis of oral squamous cell carcinoma through circ_0008898-mediated pathway.
    Dong H; Zhou W; Han L; Zhao Q
    Chem Biol Drug Des; 2024 Jan; 103(1):e14393. PubMed ID: 37955304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circ-HIPK3 regulates YAP1 expression by sponging miR-381-3p to promote oral squamous cell carcinoma development.
    Bi L; Zhang C; Yao Y; He Z
    J Biosci; 2021; 46():. PubMed ID: 33737493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0008068 facilitates the oral squamous cell carcinoma development by microRNA-153-3p/acylgycerol kinase (AGK) axis.
    Long Y; Li C; Zhu B
    Bioengineered; 2022 May; 13(5):13055-13069. PubMed ID: 35635053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircPVT1 facilitates the progression of oral squamous cell carcinoma by regulating miR-143-3p/SLC7A11 axis through MAPK signaling pathway.
    Wang S; Li W; Yang L; Yuan J; Wang L; Li N; Zhao H
    Funct Integr Genomics; 2022 Oct; 22(5):891-903. PubMed ID: 35624316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA_0076977 contributes to oral squamous cell carcinoma progression through mediating microRNA-802 axis.
    Hei N; Chen Y; Peng S; Bao Y; Jin L
    Arch Oral Biol; 2022 Dec; 144():105567. PubMed ID: 36265392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ-KIAA0907 inhibits the progression of oral squamous cell carcinoma by regulating the miR-96-5p/UNC13C axis.
    Dong W; Zhao L; Zhang S; Zhang S; Si H
    World J Surg Oncol; 2021 Mar; 19(1):75. PubMed ID: 33715625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
    Zhu X; Du J; Gu Z
    Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircRNA circ_0067772 aggravates the malignant progression of cutaneous squamous cell carcinoma by regulating miR-1238-3p/FOXG1 axis.
    Li X; Kong Y; Li H; Xu M; Jiang M; Sun W; Xu S
    Genes Genomics; 2021 May; 43(5):491-501. PubMed ID: 33709381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ_SEC61A1 contributes to the progression of multiple myeloma cells via regulating miR-660-5p/CDK6 axis.
    Luo Z; Yin Y; Tan X; Liu K; Chao Z; Xia H
    Leuk Res; 2022 Feb; 113():106774. PubMed ID: 35030455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of hsa_circ_0009035 Suppresses Cervical Cancer Progression and Enhances Radiosensitivity through MicroRNA 889-3p-Dependent Regulation of HOXB7.
    Zhao X; Dong W; Luo G; Xie J; Liu J; Yu F
    Mol Cell Biol; 2021 May; 41(6):e0063120. PubMed ID: 33782039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-504 functions as a tumor suppressor in oral squamous cell carcinoma through inhibiting cell proliferation, migration and invasion by targeting CDK6.
    Wang X; Chang K; Gao J; Wei J; Xu G; Xiao L; Song G
    Int J Biochem Cell Biol; 2020 Feb; 119():105663. PubMed ID: 31812760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p.
    Zheng Y; Duan L; Yang Y; Luo D; Yan B
    Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circ_0109291 Promotes Cisplatin Resistance of Oral Squamous Cell Carcinoma by Sponging miR-188-3p to Increase
    Gao F; Han J; Wang Y; Jia L; Luo W; Zeng Y
    Cancer Biother Radiopharm; 2022 May; 37(4):233-245. PubMed ID: 32758011
    [No Abstract]   [Full Text] [Related]  

  • 18. Blocking circ-SCMH1 (hsa_circ_0011946) suppresses acquired DDP resistance of oral squamous cell carcinoma (OSCC) cells both in vitro and in vivo by sponging miR-338-3p and regulating LIN28B.
    Qiu F; Qiao B; Zhang N; Fang Z; Feng L; Zhang S; Qiu W
    Cancer Cell Int; 2021 Aug; 21(1):412. PubMed ID: 34353342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. circ-PKD2 inhibits carcinogenesis via the miR-204-3p/APC2 axis in oral squamous cell carcinoma.
    Gao L; Zhao C; Li S; Dou Z; Wang Q; Liu J; Ren W; Zhi K
    Mol Carcinog; 2019 Oct; 58(10):1783-1794. PubMed ID: 31206208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of miR-519d-3p Inhibits Viability, Proliferation, and G1/S Cell Cycle Transition of Oral Squamous Cell Carcinoma Cells Through Targeting CCND1.
    Zhang W; Hong W
    Cancer Biother Radiopharm; 2024 Mar; 39(2):153-163. PubMed ID: 33052706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.